4D Molecular Therapeutics, Inc. (FDMT) analyst actions
Rating and price-target actions on FDMT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the FDMT overview →
1 measured FDMT analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| 4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME | Press release | -0.80% | +0.62% |
Keep exploring
More FDMT: earnings → · SEC filings → · FDMT overview →